Skip to main content
logo
Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.000
+0.170 (4.44%)
Jan 28, 2026, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Regulatory Ribonucleic Acid-based Therapeutics
652.00K
Log In
Regulatory Ribonucleic Acid-based Therapeutics Growth
86.29%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
652.00K
Log In
United States Growth
86.29%
Log In